BATS BZX Real-Time Price
As of 2:55pm ET
| -0.39 / -8.88%|
The 7 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +50.00% increase from the last price of 4.00.
The current consensus among 9 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.